The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...
“You can think of this as a living medical device that is made from human cells that secrete insulin, along with an electronic life-support system." Reading time 3 minutes MIT scientists might be one ...
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...
(ARA) - Nearly 26 million people in the United States have diabetes and the population continues to grow. There are approximately 5.5 million people in the U.S. who depend on daily insulin injections ...
People with diabetes have more than a few hassles, particularly at meals. They not only have to measure their blood glucose levels and inject the right amount of insulin, but carry all the relevant ...
Years after initiating a pair of Class I recalls for various models of its MiniMed insulin pumps—one due to a faulty locking component and the other because of cybersecurity issues with a remote ...
In brief: Scientists have spent decades trying to find a cure for type 1 diabetes, an autoimmune condition with no known cause. While reprogramming a human body so it stops attacking the pancreatic ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...
One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results